The first clinical trial of a drug intended to delay the onset of symptoms of Huntington disease reveals that high-dose treatment with the nutritional supplement creatine was safe and well tolerated by most participants. In addition, neuroimaging showed a treatment-associated slowing of regional brain atrophy, evidence that creatine might slow the progression of presymptomatic disease.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/M...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/M...